Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women

Int Immunopharmacol. 2015 Sep;28(1):477-86. doi: 10.1016/j.intimp.2015.07.015. Epub 2015 Jul 18.

Abstract

Objectives: The aim of the study was to evaluate the frequency of gene polymorphisms OPG -163A/G, -950T/C and 1181G/C, assessing their relations with the clinical parameters of osseous turnover and the degree of postmenopausal osteoporosis.

Study design: The study included 800 women of postmenopausal (505) and reproductive (295) age from Poland. The postmenopausal group included women with osteoporosis and osteopenia, as well as healthy individuals. All the women of reproductive age were healthy. The frequency of the tested gene polymorphisms was evaluated within the group where BMD (bone mineral density) was marked and also in the control group.

Main outcome measures: The frequencies of the polymorphisms of OPG genotypes in the women were characteristic of the population.

Results: OPG -950T/C polymorphism has been associated with body weight and birth weight. OPG 1181G/C and OPG -163A/G polymorphisms have been associated not only with body weight and birth weight, but also with reduced bone density and an increased risk of postmenopausal osteoporosis.

Conclusions: Evaluation of the polymorphism -950T/C of the OPG gene showed that the CC genotype may appear as an increased risk factor for the faster loss of bone mass and the onset of osteoporosis in Polish postmenopausal women. This polymorphism may be a genetic marker that is responsible for the development of osteoporosis. The homozygous genotypes of polymorphisms 1181G/C and -163A/G of the OPG gene may play a role in increased risks of osteoporosis and may be linked to the birth weights of women.

Keywords: Age; Females; Osteoporosis; Osteoprotegerin; Polymorphism.

MeSH terms

  • Adult
  • Bone Density / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal / genetics*
  • Osteoprotegerin / genetics*
  • Polymorphism, Genetic
  • Postmenopause / genetics*
  • Premenopause / genetics*

Substances

  • Osteoprotegerin